Table 1.

Baseline demographics and patient characteristics (N = 68)

Age, y
 Median54.0
 Range26–84
Sex, n (%)
 Male44 (64.7)
 Female24 (35.3)
Race or ethnic background, n (%)
 White66 (97.1)
 Black or African American2 (2.9)
ECOG score, n (%)a (n = 67)
 021 (31.3)
 143 (64.2)
 23 (4.5)
Tumor type, n (%)
 Basal cell carcinoma33 (48.5)
 Pancreatic8 (11.8)
 Colorectal3 (4.4)
 Mesothelioma3 (4.4)
 Small cell lung3 (4.4)
 Adenocystic carcinoma2 (2.9)
 Adrenocortical carcinoma2 (2.9)
 Parotid gland2 (2.9)
 Prostate2 (2.9)
 Medulloblastoma1 (1.5)
 Otherb9 (13.2)
Previous therapies, n (%)
 Surgery67 (98.5)
 Radiotherapy36 (52.9)
 Systemic therapyc48 (70.6)

aECOG scores ranging from 0 to 5, with higher scores indicating a greater severity of illness.

bOther tumor types included one each of appendix, bladder, carcinoid, chondrosarcoma, endometrial, gastric, liver/biliary, melanoma, and renal.

cIncludes hormonal, other biologic, chemotherapy, and other systemic therapy.